Thursday, 05 May 2022
Members of the public are invited learn how this important area of research will be addressed and to officially see the launch of the Advance Pain Discover Platform (APDP), at a webinar on the 9 May from 10am – 12midday.
The problem of pain still blights the lives of far too many people. Around a third of the population in Britain have chronic pain. This long-lasting pain affects so many aspects of people’s lives, their ability to work and personal relationships.
The UK has been the cornerstone of pain research. The APDP is a new, unique partnership that has developed from a shared vision, funded by government, charities and the private sector. It is a multi-million pound, long-term initiative that will generate research science to break through the complexity of pain.
The APDP brings people with lived experience of pain together with UK excellence in chronic pain research across diagnoses, disciplines, academic, clinical and commercial communities.
Together, through the APDP, we will transform people鈥檚 understanding of pain. We will uncover shared mechanisms and break down inconsistencies in diagnosis and treatment.
"We will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.鈥�
鈥淲e will uncover genes and molecules, brain structure and function, psychological and social mechanisms, drug and non-drug treatments. Those who are forced to live with intolerable pain are being noticed. Our multidisciplinary approach will ultimately improve the lives of people living with pain conditions and their families.鈥�
The webinar will convey for a public audience the specific and shared ambitions of each of the 18 current APDP components. Attendees will see the depth and breadth of UK capability in pain research, and have an opportunity to initiate new links with our experts.
To register to attend the webinar visit -
Notes to editors:
About the 糖心原创
Ranked 97 in the world and 17th in the UK by the , the 糖心原创 is a founding member of Russell Group of research-intensive universities. 糖心原创ing at the 糖心原创 is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.
Nottingham was crowned Sports University of the Year by 鈥� the third time it has been given the honour since 2018 鈥� and by the .
The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.
The university is a major employer and industry partner - locally and globally - and our graduates are the third most targeted by the UK's top employers, according to The Graduate Market in 2024 report by High Fliers Research. Alongside Nottingham Trent University, we lead the , a pioneering collaboration between the city鈥檚 two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.